Biotech investing is not for the faint-hearted. This field, ruled by unpredictability, is a theatre of sharp turns: clinical trials that vault or vaporize fortunes, regulatory whims that recast the rules, and groundbreaking science that reshapes entire markets. Investors, yearning for clarity in the chaos, often cling to deceptively

Hi, I’m Sebastian, and this blog is both an indulgence and an exploration. It’s not for any one person, and yet, perhaps, for everyone. Over the past decade, I’ve worked across nearly every facet of the pharmaceutical industry, helping companies connect through Slate Mountains Capital and the